Marshall Wace LLP Has $3.02 Million Position in The Procter & Gamble Company (NYSE:PG)

Marshall Wace LLP reduced its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 99.4% during the 2nd quarter, HoldingsChannel reports. The firm owned 18,315 shares of the company’s stock after selling 3,091,728 shares during the quarter. Marshall Wace LLP’s holdings in Procter & Gamble were worth $3,021,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Alera Investment Advisors LLC raised its position in shares of Procter & Gamble by 1.2% in the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after purchasing an additional 60 shares during the period. Hudson Value Partners LLC increased its holdings in Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock worth $250,000 after acquiring an additional 60 shares during the period. Fiduciary Alliance LLC increased its holdings in Procter & Gamble by 2.8% during the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock worth $371,000 after acquiring an additional 61 shares during the period. LCM Capital Management Inc increased its holdings in Procter & Gamble by 1.1% during the 1st quarter. LCM Capital Management Inc now owns 5,701 shares of the company’s stock worth $925,000 after acquiring an additional 63 shares during the period. Finally, Home Federal Bank of Tennessee increased its holdings in Procter & Gamble by 0.3% during the 2nd quarter. Home Federal Bank of Tennessee now owns 23,318 shares of the company’s stock worth $3,846,000 after acquiring an additional 63 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Trading Down 1.1 %

NYSE:PG opened at $170.06 on Friday. The company has a fifty day moving average of $171.15 and a 200 day moving average of $166.43. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $177.94. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $401.37 billion, a P/E ratio of 27.79, a P/E/G ratio of 3.76 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The company had revenue of $20.53 billion during the quarter, compared to analyst estimates of $20.69 billion. During the same period in the prior year, the business posted $1.37 EPS. The firm’s revenue was down .1% compared to the same quarter last year. On average, research analysts predict that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were issued a $1.0065 dividend. The ex-dividend date was Friday, July 19th. This represents a $4.03 annualized dividend and a yield of 2.37%. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.

Analysts Set New Price Targets

A number of research firms recently weighed in on PG. BNP Paribas began coverage on shares of Procter & Gamble in a report on Monday, June 24th. They set an “outperform” rating and a $187.00 target price on the stock. Stifel Nicolaus upped their target price on shares of Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a report on Monday, July 22nd. Evercore ISI upped their target price on shares of Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a report on Thursday, July 18th. Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Finally, Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research note on Monday. Nine analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $175.89.

View Our Latest Research Report on Procter & Gamble

Insiders Place Their Bets

In other Procter & Gamble news, CEO R. Alexandra Keith sold 3,373 shares of the company’s stock in a transaction on Monday, August 5th. The shares were sold at an average price of $170.00, for a total value of $573,410.00. Following the completion of the transaction, the chief executive officer now directly owns 21,513 shares in the company, valued at approximately $3,657,210. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO R. Alexandra Keith sold 3,373 shares of the stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $170.00, for a total transaction of $573,410.00. Following the completion of the transaction, the chief executive officer now owns 21,513 shares of the company’s stock, valued at $3,657,210. The disclosure for this sale can be found here. In the last ninety days, insiders sold 383,194 shares of company stock worth $65,140,718. 0.17% of the stock is currently owned by corporate insiders.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.